Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

Abstract Introduction The V-GOOD study evaluated the effectiveness of trimetazidine modified-release (MR) 80 mg once daily (OD) in patients with chronic coronary syndrome (CCS) who remained symptomatic despite antianginal therapies in routine clinical practice. Methods This prospective, observationa...

Full description

Saved in:
Bibliographic Details
Main Authors: Luís Henrique Wolff Gowdak, Paulo Magno Martins Dourado, Dalton Bertolim Précoma, César de Oliviera Lopes Dusilek, Francisco Maia da Silva, Juan Carlos Yugar-Toledo, Felipe Montes Pena, Domingos Antônio de Almeida Gomes, Elizabeth do Espírito Santo Cestário, Olavo Raimundo Guimarães, Conrado Roberto Hoffmann Filho, Carlos Filinto de Almeida, Flávio de Souza Brito, Gerez Fernandes Martins, Victor Rodrigues Ribeiro Ferreira, Marcella Chaves Flores, Mayara Lídia da Silva, on behalf of the V-GOOD Investigators
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-04-01
Series:Cardiology and Therapy
Subjects:
Angina pectoris
Chronic coronary syndrome
Stable angina
Trimetazidine
Online Access:https://doi.org/10.1007/s40119-025-00405-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40119-025-00405-9

Similar Items